Manage psychiatric and/or substance use comorbidities in patients with hepatitis C virus infection to improve antiviral outcomes

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.10, 2006-10, pp. : 14-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C Virus Infection and Antiviral Treatment in Marginal Zone Lymphomas

By  

Current Clinical Pharmacology, Vol. 5, Iss. 2, 2010-05 ,pp. : 74-81

Bentham Science Publishers

Access to resources Recommend Favorite

Psychiatric and Substance Use Disorders in Individuals with Hepatitis C: Epidemiology and Management

By Loftis Jennifer M.   Matthews Annette M.   Hauser Peter  

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 155-174

Adis International

Access to resources Recommend Favorite

Anti-Viral Therapies for Hepatitis C Virus Infection: Current Options and Evolving Candidate Drugs

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 150-161

Bentham Science Publishers

Access to resources Recommend Favorite

Emtricitabine shows antiviral activity in patients with chronic hepatitis B virus (HBV) infection

By  

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Resistance of hepatitis C virus to the host antiviral response

By Polyak Stephen  

Future Virology, Vol. 1, Iss. 1, 2006-01 ,pp. : 89-98

Future Medicine

Access to resources Recommend Favorite